Skip to content
Recall Observatory FDA recall evidence

Drug product

Levoxyl (levothyroxine sodium) tablets, USP, 75 mcg, packaged in a) 100-count bottles (NDC 60793-852-01) and b) 1000-count bottles (NDC 60793-852-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620

D-423-2013

April 30, 2013

Class II

Product summary

Firm
King Legacy, a wholly owned subsidiary of Pfizer
Event
Event 65172
Status
Terminated
Classification
Class II
Quantity
194,142 bottles
Official record key
drug-enforcement:D-423-2013

Official wording

Reason: Subpotent Drug: The products were below specification for potency at the expiry stability point.

Code information: Lot # a) 64197, Exp. 4/13; 64339, Exp. 4/13; 65061, Exp. 5/13; 65236, Exp. 6/13; 65917, Exp. 8/13; 66122, Exp. 8/13; and 66427, Exp. 9/13; b) 64340, Exp. 4/13; 64933, Exp. 4/13; 65062, Exp. 5/13; 65237, Exp. 6/13; 65238, Exp. 6/13; and 66121, Exp. 8/13

Distribution pattern: Nationwide and Puerto Rico

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent

Field note

Send feedback

We'll only use this to respond to your feedback.